SectorHealthcare Equipment and Supplies
Established Date--
Listing Date30/01/1997
ExchangeNASDAQ Stock Exchange
Full-time Employees275
Fiscal Year Ends31/12
Security TypeCommon stock
Office address1220 Concord Avenue, Suite 600, Concord, California 94520
Business
IntroductionCerus Corporation, founded in California in 1991 and re-incorporated in Delaware in 1996. The Company is a biomedical products company focused on developing and commercializing the INTERCEPT blood system to enhance blood safety. The Company's INTERCEPT blood system is designed to work with blood components and certain of their derivatives: platelets, plasma, red blood cells and the production of INTERCEPT fibrinogen complex, or IFC, as well as pathogen-reducing plasma, cryoprecipitate reduction.
